Bendamustine
Bendamustine is a chemotherapy medication used in the treatment of certain types of cancer. It is classified as an alkylating agent and is primarily used to treat chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). Bendamustine is known for its unique mechanism of action, which combines properties of both alkylating agents and antimetabolites.
Medical Uses[edit]
Bendamustine is indicated for the treatment of:
- Chronic lymphocytic leukemia (CLL)
- Non-Hodgkin lymphoma (NHL), particularly in patients who have not responded to other treatments
Mechanism of Action[edit]
Bendamustine works by causing DNA damage in cancer cells, which leads to cell death. It forms cross-links between DNA strands, preventing the cancer cells from dividing and growing. This dual mechanism of action, involving both alkylation and antimetabolite activity, makes bendamustine effective against cancer cells that may be resistant to other treatments.
Administration[edit]
Bendamustine is administered intravenously. The dosage and treatment schedule depend on the type of cancer being treated, the patient's overall health, and other factors. It is typically given in cycles, with periods of treatment followed by periods of rest.
Side Effects[edit]
Common side effects of bendamustine include:
- Nausea
- Vomiting
- Fatigue
- Fever
- Infections due to lowered white blood cell counts
- Anemia
- Thrombocytopenia
Serious side effects can include severe infections, allergic reactions, and secondary cancers.
History[edit]
Bendamustine was first synthesized in the 1960s in the former East Germany. It was approved for medical use in the United States by the Food and Drug Administration (FDA) in 2008.
Research[edit]
Ongoing research is exploring the use of bendamustine in combination with other chemotherapy agents and targeted therapies to improve outcomes for patients with various types of cancer.
See Also[edit]
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
.png){kind=link}